Skip to main content
HairCited

Microneedling für Androgenetische Alopezie

A

Basierend auf 52 Studien (5 meta-analyses, 11 RCTs) mit 8,451 Teilnehmern insgesamt. 44/52 Studien zeigen positive Effekte.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'haircited.com'; const params = 'ingredient\u003Dmicroneedling\u0026condition\u003Dandrogenetic\u002Dalopecia'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

A

Fazit

Microneedling has strong, well-established evidence for androgenetic alopecia, particularly when combined with topical minoxidil, and is one of the best-supported adjunct therapies for pattern hair loss.

  • 44 out of 52 studies show positive effects, supported by 5 meta-analyses and 11 RCTs
  • Most effective when combined with topical minoxidil, significantly boosting its effectiveness
  • Stimulates growth factors and wound-healing pathways that support hair follicle regeneration
  • Both professional and at-home microneedling approaches have demonstrated benefits

Key Study Findings

non-randomized controlled trial n=60 16 weeks Open-label
Clinical Efficacy and Mechanisms of Microneedling Alone or Combined With Drugs in the Treatment of …
Dose: Mild group: microneedling alone (8 weeks); Moderate group: microneedling + 5% minoxidil (12 weeks); vs.: Placebo Wirkung: All groups showed significant decrease in HLSS and increase in hair density post-treatment (p<0.001) p<0.001
Controlled Clinical Trial n=8 12 weeks Single-blind
Dutasteride Infusion in Male Androgenetic Alopecia Using a Novel Drug Delivery Technique: MMP®.
Dose: 3 sessions of dutasteride microinfusion (monthly) vs.: Saline solution placebo via MMP Outcome: Clinical assessment and patient self-assessment Wirkung: None None

Population: Adult males with androgenetic alopecia

Review
Microneedling Combined With Drugs and Stem Cells for Treating Androgenetic Alopecia.
Dose: None vs.: None Outcome: None Wirkung: None None

Population: None

review
The role of microtrauma in hair regrowth and regeneration in non-scarring alopecia.
Dose: Various microtrauma procedures: microneedling, fractional/non-fractional lasers, contact immunothera vs.: Placebo Wirkung: Positive outcomes reported for hair density and thickness with microneedling, lasers, LLLT, and PRP None
scoping_review n=16
A Scoping Review of Exosome Delivery Applications in Hair Loss.
Dose: variable; exosomes predominantly from mesenchymal stem cells (MSCs) vs.: Placebo Wirkung: None None

Key Statistics

62

Studien

8574

Teilnehmer

Positive

A

Bewertung

Referenced Papers

Aesthetic plastic surgery 2025 14 Zitierungen
Journal of cutaneous … 2025 2 Zitierungen
Dermatology (Basel, Switzerland) 2024 14 Zitierungen
Journal of cosmetic … 2024 11 Zitierungen
Journal of clinical … 2024 10 Zitierungen
Clinical, cosmetic and … 2023 58 Zitierungen
Skin appendage disorders 2023 4 Zitierungen
Faculty reviews 2022 44 Zitierungen
Dermatology and therapy 2022 43 Zitierungen
Journal of cosmetic … 2022 35 Zitierungen
Dermatologic surgery : … 2022 15 Zitierungen
Dermatologic surgery : … 2021 58 Zitierungen
Dermatologic therapy 2020 48 Zitierungen
Journal of plastic, … 2018 137 Zitierungen
Journal of the … 2018 114 Zitierungen

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Übliche Dosierungen

hairloss:
1.5 mm depth, weekly sessions

Obergrenze: Not applicable

In der Forschung untersuchte Dosierungen

Dosierung Dauer Wirkung N
Mild group: microneedling alone (8 weeks); Moderate group: microneedling + 5% minoxidil (12 weeks); 16 weeks Positive 60
3 sessions of dutasteride microinfusion (monthly) 12 weeks Positive 8
None -- Mixed --
Various microtrauma procedures: microneedling, fractional/non-fractional lasers, contact immunothera -- Positive --
None -- Mixed --
variable; exosomes predominantly from mesenchymal stem cells (MSCs) -- Positive 16
None -- Positive 631
None -- Mixed --

Beste Einnahmezeit: Weekly sessions; avoid minoxidil for 24 hours post-treatment

Safety & Side Effects

Gemeldete Nebenwirkungen

  • Scalp redness and inflammation (24-72 hours)
  • Mild bleeding at treatment site
  • Scalp tenderness and soreness
  • Rare: infection if proper sterilization not maintained

Bekannte Wechselwirkungen

  • Topical minoxidil (enhanced absorption; wait 24 hours after microneedling to apply)
  • Blood thinners (may increase bleeding during procedure)
  • Topical retinoids (discontinue 3-5 days before treatment)

Tolerierbare Höchstaufnahmemenge: Not applicable

Konsultieren Sie immer Ihren Arzt, bevor Sie ein Nahrungsergänzungsmittel einnehmen.Konsultieren Sie immer Ihren Arzt, bevor Sie ein Nahrungsergänzungsmittel einnehmen.

Frequently Asked Questions

Does Microneedling help with Androgenetische Alopezie?
Based on 62 studies with 8,574 participants, there is strong evidence from multiple clinical trials that Microneedling may support Androgenetische Alopezie management. Our evidence grade is A (Strong Evidence).
How much Microneedling should I take for Androgenetische Alopezie?
Studies have used various dosages. A commonly studied range is 1.5 mm depth, weekly sessions. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Microneedling?
Reported side effects may include Scalp redness and inflammation (24-72 hours), Mild bleeding at treatment site, Scalp tenderness and soreness, Rare: infection if proper sterilization not maintained. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Microneedling and Androgenetische Alopezie?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 62 peer-reviewed studies with 8,574 total participants. The overall direction of effect is positive.

Related Evidence

FDA-Haftungsausschluss: Diese Aussagen wurden nicht von der Food and Drug Administration bewertet. Die Produkte und Informationen auf dieser Website sind nicht dazu bestimmt, Krankheiten zu diagnostizieren, zu behandeln, zu heilen oder zu verhindern. Die dargestellten Evidenzbewertungen basieren auf unserer Analyse veröffentlichter begutachteter Forschung und stellen keine medizinische Beratung dar. Konsultieren Sie immer Ihren Arzt, bevor Sie mit der Einnahme von Nahrungsergänzungsmitteln beginnen.